Please login to the form below

Not currently logged in
Email:
Password:

Pfizer veteran joins Dynavax board

Natale Ricciardi spent 39 years at pharma giant

Dynavax Natale RicciardiNatale Ricciardi has joined the board of Dynavax Technologies two years after retiring from Pfizer.

Ricciardi spent 39 years at Pfizer, advancing to president of the pharma giant's global manufacturing business and senior VP of its North American operations.

He was also a member of the Pfizer executive leadership team when he retired in 2011.

Dynavax, which focuses on developing products to prevent and treat infectious and inflammatory diseases, will benefit from this senior experience as it looks to bring to market its lead product candidate, the hepatitis B vaccine Heplisav.

"On behalf of Dynavax, we are delighted to welcome Nat to the board,” said Arnold Oronsky, chairman of the board at Dynavax.

“His experienced leadership, particularly in global manufacturing, will provide valuable insight to the company and we look forward to his contributions."

10th July 2013

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Page & Page and Partners

For those who can imagine better, Page & Page and Partners (P&P) is home to meaningful encounters of a marketing, communication...

Latest intelligence

Personalised medicine AI
How early-stage clinical research is facilitating the new wave of personalised medicines
By Jorg Taubel...
patient diversity buckland
Patient diversity in clinical trials needs to be centre stage
By Danny Buckland...
Why empathy in digital patient recruitment is vital
This is where empathy mapping can be incredibly effective....